Caveat Emptor

Thoughts about Investing in China Market I have recently ventured for a leisure trip to Shen Zhen and Guangzhou. Considering that a significant part of my portfolio is exposed to China market (Raffles Medical, OCBC, Tencent, HKEX), a trip to China has been on my bucket list for both professional and personal reasons. The reputation of ShenZhen as the silicon valley of the east indeed lives up to its name. I am very impressed by the contrasting differences in the retail landscape in China as compared to Singapore, as well as the potential of the China Market. Myth 1 : Any company exposed to China is bound to make it rich. If you manage to sell even a dollar to everyone in China, you will instantly be a millionaire. Reality : The retail landscape of China is insanely competitive. A scuttlebutt analysis at Fraser Suites Guangzhou exhibited a stark contrast with Singapore retail landscape, whereby even popular locations can have vacant stores. With Alibaba and JinDong (JD.com),

Personal notes on banking industry After allocating a substantial amount of war-chest into equity markets, it is time to stand down and observe the macro-economic events (trade war) that may affect the financial performance of underlying real businesses. The Federal Reserve is yet again doing a fine job of managing expectations of global participants by engaging in double speak . As the saying goes, if you can't convince, confuse. As I have no crystal ball to foresee the future, I shall consolidate my notes on the banking sector so that I will be prepared to capitalize on any opportunities that may materialize based on the latest Fed moves. Richard Tay Jun Hao had recently provided an useful web seminar on the banking sector and I shall amalgamate the lessons I learnt from his sharing with my personal knowledge base to better identify the better performing local and foreign banks. 1) Business Model Net Interest Income = Interest income – interest expense Net interest mar

Stock Name Mode Qty Avg Cost Price Total Cost Percentage ASCENDAS-ITRUST CSH 2500 1.13 ASCENDAS-ITRUST 2,812.50 20.5554540471 ASCENDAS REIT CSH 1000 2.25 ASCENDAS REIT 2,250.00 16.4443632377 HYFLUX CSH 4000 0.57 HYFLUX 2,260.00 16.5174492965 RAFFLES MEDICAL CSH 2000 1.31 RAFFLES MEDICAL 2,610.00 19.0754613557 SINGTEL CSH 1000 3.75 SINGTEL 3,750.00 27.4072720629 STI ETF (Philips) Philips DCA 1859 3.047 STI ETF (Philips) 5664.373 41.3986698337 Singtel Maybank Cust 300 3.68 Singtel 1109.19 8.1066325598 STI ETF Maybank DCA 118 3.25 STI ETF 390.16 2.8515256715 Silverlake Axis Maybank Cust 2000 0.59 Silverlake Axis 1201.21 8.7791704732 Portfolio Book Value